about
Different strategies for using topical corticosteroids for established eczemaPsychological and educational interventions for atopic eczema in childrenTopical pimecrolimus for eczemaPsychological and educational interventions for atopic eczema in childrenRandomized, controlled trial evaluating a baby wash product on skin barrier function in healthy, term neonatesParents' reported preference scores for childhood atopic dermatitis disease statesStigmatization and self-perception in children with atopic dermatitisA Review of Multidisciplinary Interventions in Atopic DermatitisHealth outcome measures in atopic dermatitis: a systematic review of trends in disease severity and quality-of-life instruments 1985-2010.Measurement properties of quality-of-life measurement instruments for infants, children and adolescents with eczema: a systematic review.Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials.Efficacy and safety of 15(R/S)-methyl-lipoxin A(4) in topical treatment of infantile eczema.What's new in atopic dermatitis?Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis.Eczema, sleep, and behavior in children.The expert network and electronic portal for children with respiratory and allergic symptoms: rationale and design.Allergy: a global problem. Quality of life.International Consensus Conference on Atopic Dermatitis II (ICCAD II): clinical update and current treatment strategies.Quality-of-life outcomes and measurement in childhood atopic dermatitisA pilot comparison study of four clinician-rated atopic dermatitis severity scales.Quality of life measures in Italian children with atopic dermatitis and their families.The benefits of Tubifast Garments in the management of atopic eczema.Stress in mothers of young children with eczema.Quality of life and disease severity are correlated in patients with atopic dermatitisThe psychosocial burden of childhood atopic dermatitis.Clinical management of atopic eczema with pimecrolimus cream 1% (Elidel) in paediatric patients.Supporting self-care for families of children with eczema with a Web-based intervention plus health care professional support: pilot randomized controlled trial.Costs and cost-effectiveness analysis of treatment in children with eczema by nurse practitioner vs. dermatologist: results of a randomized, controlled trial and a review of international costs.Systematic literature review and evaluation of patient reported outcome measures (PROMs) for asthma and related allergic diseases.Clinical experience and psychometric properties of the Children's Dermatology Life Quality Index (CDLQI), 1995-2012.The Dermatitis Family Impact questionnaire: a review of its measurement properties and clinical application.Infants' Dermatitis Quality of Life Index: a decade of experience of validation and clinical application.EADV Taskforce's recommendations on measurement of health-related quality of life in paediatric dermatology.Family quality of life among families of children with atopic dermatitis.Sleep patterns of young children with newly diagnosed atopic dermatitis.Patient-reported outcome measures for allergy and asthma in children.Emollients and moisturisers for eczema.Efficacy and safety of wet wrap therapy for patients with atopic dermatitis: a systematic review and meta-analysis.Broader concepts of quality of life measurement, encompassing validation.The effect of a Web-based education programme (WBEP) on disease severity, quality of life and mothers' self-efficacy in children with atopic dermatitis.
P2860
Q24199012-2FA10FFE-B9C9-47C1-A337-D8FFE046BA29Q24201204-6EF1655E-ECFF-4D14-BFC1-906C9739DDB9Q24243250-49A178DC-CD21-42E0-A544-44368586304CQ24244383-07914598-6655-49FF-B820-B9D7FB82E485Q24619472-7FEC62AE-994A-4F84-A60E-D67996760CB2Q24795485-CBCAFD8F-21D2-41B6-A2AF-273E42D0DBDBQ26738669-6E8DC203-9712-4F73-A87C-171B4B59743BQ26799480-4C4AB413-DBD7-4C28-A070-2206B8F88CF0Q27691377-9DA729F6-5CBA-4F29-8036-CE6D96EBB5C2Q30248379-DC684FCC-1C31-4116-B3B3-EB8EAAD9A928Q31149849-4F9FCBEF-972E-421E-85FA-288DD075C3D5Q34290400-9B51F5B2-E9A0-4475-81D3-617AF361D064Q34352747-1C90C1DB-AEEC-4F73-8075-5782ED5E0739Q34388802-E0B39AB5-04E0-4DA7-BFEC-1B28E903449DQ34458251-9DB73B7B-6260-45C6-A6A5-935A39FF39B7Q34549851-2CBFCE6E-6E3F-4005-89CD-68A679466937Q35015757-14092C5F-F392-4EBC-8604-9E4208F6CFA9Q35106685-4FD05D27-5268-4D5E-9EF2-64C7138D73C9Q35148180-57CA56F7-5DD5-42C2-8931-D1F27BF3277CQ35609349-3A1C0F2B-38A7-4818-B738-0D686D51A12FQ35779801-587B1375-3188-43C8-B617-0B437256EA8AQ36131902-33899F29-D3F2-4E0B-9B4F-287DDC999210Q36155772-17AAC685-C338-409D-9955-5F83CFA13909Q36381901-C745411C-E5E1-4DFD-8D22-F030F821E2B1Q36466789-16C3642A-AC47-45B2-8581-19EDECD883A4Q37049981-E0D0DB1B-9E2C-471E-B2C9-5A606F8291E7Q37653856-70982CFE-5AC6-4999-BC39-F2C012579874Q37892602-56FC10AE-5E87-4A81-AE0E-2AA2D0D6A3F5Q38045730-24E1FF0A-DA8B-462D-BDA3-E253C788CCD9Q38107270-188C59A0-A677-4414-92E1-7490B450C788Q38119984-DE1CB43A-A30C-437F-825C-D437463211DAQ38126112-83306565-D439-4A75-AD47-08344E5B7E92Q38416809-DD5534A5-3AAA-490E-A0B2-7DFEFB7AE6ABQ38558873-12E5790E-C3A8-4F2C-A07C-5C7016D135D8Q38784558-E2D04AAA-FFD3-4737-8B01-D454C3C4C134Q38862219-1FB544B7-4B39-4D46-8AFF-5A8502547613Q38976344-FF2B3FF6-F8AA-4A5A-A780-AAF94C7D30BAQ39012776-6A6DA4CD-FA11-45BF-B523-3211F5A451FCQ39215992-FABF1127-30A4-4E9B-8E46-2581242C69CEQ39227811-15278752-F814-407E-B210-72FCF99414DE
P2860
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
The Infants' Dermatitis Quality of Life Index.
@en
The Infants' Dermatitis Quality of Life Index.
@nl
type
label
The Infants' Dermatitis Quality of Life Index.
@en
The Infants' Dermatitis Quality of Life Index.
@nl
prefLabel
The Infants' Dermatitis Quality of Life Index.
@en
The Infants' Dermatitis Quality of Life Index.
@nl
P2860
P1476
The Infants' Dermatitis Quality of Life Index.
@en
P2093
Lewis-Jones MS
P2860
P304
P356
10.1046/J.1365-2133.2001.03960.X
P407
P577
2001-01-01T00:00:00Z